USB

Truist and U.S. Bancorp are writing shareholders identical checks this year, but underneath that matching number, one bank is quietly building momentum while the other sits frozen in place.

U.S. Bancorp has delivered a very strong 91.5% share price gain over the past three years, yet several valuation checks still point to the stock trading below an estimate of its intrinsic value. For investors, the focus is on how that gap between the market price and the Excess Returns model compares with a more mixed overall value score. The 91.5% three year return suggests U.S. Bancorp has alrea

U.S. Bancorp (NYSE: USB) announced a significant expansion of its business banking operations into Florida, Georgia, Texas, and Arizona. The move targets mid-sized businesses in Sun Belt states where U.S. Bank currently has a limited presence. The expansion includes a sizable hiring effort as the company seeks a broader national footprint. This push by U.S. Bancorp into business hubs in these regi

GMO’s 13F portfolio jumps to ~$44B. See top holdings, key buys/sells, and rebalancing across tech, healthcare & financials—read the update now.

Kedia exercised vested stock options at $55.01 per share and immediately sold them at $62.37, retaining a direct stake of 426,262 shares worth approximately $26.6 million.

KRE bundles roughly 140 regional banks into one tidy package, but that diversification comes at a quiet cost to dividend growth and total return that most income investors never stop to measure.

US Bancorp expansion is accelerating with 50-plus new client-facing roles across Florida, Georgia, Texas, and Arizona this year.

Florida, Georgia, Texas and Arizona are all states where U.S. Bank, which operates mainly in the Midwest and the West, sees growth opportunities.